Crysta Ivf Life Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 01-11-2024
- Paid Up Capital ₹ 0.41 M
as on 01-11-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -31.03%
(FY 2023)
- Profit -2518.89%
(FY 2023)
- Ebitda -4290.64%
(FY 2023)
- Net Worth -2229.45%
(FY 2023)
- Total Assets 37.51%
(FY 2023)
About Crysta Ivf Life
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.41 M, as per Ministry of Corporate Affairs (MCA) records.
Neeta Jain, Radhika Bagla, and Rohit Jalan serve as directors at the Company.
- CIN/LLPIN
U85300DL2021PTC376022
- Company No.
376022
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2021
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Crysta Ivf Life?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeta Jain  | Director | 22-Jun-2022 | Current |
| Radhika Bagla | Additional Director | Current | |
| Rohit Jalan | Additional Director | Current |
Financial Performance of Crysta Ivf Life.
Crysta Ivf Life Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.03% decrease. The company also saw a substantial fall in profitability, with a 2518.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2229.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crysta Ivf Life?
In 2023, Crysta Ivf Life had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Redcliffe Lifetech Private LimitedActive 3 years 10 monthsRadhika Bagla and Rohit Jalan are mutual person
- Redcliffe Lifescience Private LimitedActive 7 years 3 months
Radhika Bagla and Rohit Jalan are mutual person
- Redcliffe Life Images Private LimitedActive 3 years 2 months
Radhika Bagla and Rohit Jalan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Crysta Ivf Life?
Crysta Ivf Life has a workforce of 172 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crysta Ivf Life, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crysta Ivf Life's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
